Study #2022-0511
A randomized control trial for patient reported outcomes and safety in outpatient thyroid lobectomy
MD Anderson Study Status
Enrolling
Treatment Agent
Description
To compare same-day discharge and overnight (or longer) observation practices and learn more about the differences in patient preferences, safety outcomes, and economic and resource impact
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Thyroid Lobectomy
Study phase:
Phase II
Physician name:
Paul Graham
Department:
Surgical Oncology
For general questions about clinical trials:
1-833-670-2212
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.